Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States

Simons, CL; Malone, D; Wang, M; Maglinte, GA; Inocencio, T; Wade, SW; Bennison, C; Shah, B

Simons, CL (corresponding author), Pharmerit, Enterprise House,Innovat Way, York YO10 5NQ, N Yorkshire, England.

JOURNAL OF MEDICAL ECONOMICS, 2021; 24 (1): 421

Abstract

Aims The objective of this study is to estimate the cost-effectiveness of KTE-X19 versus standard of care (SoC) in the treatment of relapsed/refractor......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索